Clinical Trial Update: Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating the safety and tolerability of U3-1565 in patients with advanced solid tumors and advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• U3-1565

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Solid Malignant Tumors, Advanced Ovarian Cancer | Phase 1 | Status: COMPLETED